Literature DB >> 19027349

Dynamic contrast-enhanced magnetic resonance imaging for estimating tumor proliferation and microvessel density of oral squamous cell carcinomas.

Teruhisa Unetsubo1, Hironobu Konouchi, Yoshinobu Yanagi, Jun Murakami, Masae Fujii, Hidenobu Matsuzaki, Miki Hisatomi, Hitoshi Nagatsuka, Jun-ichi Asaumi.   

Abstract

We evaluated the relationship between histopathological prognostic factors, tumor proliferation microvessel density (MVD), and enhancement parameters in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in oral squamous cell carcinoma (SCC). Twenty-eight T2 and T3 patients with primary oral SCC underwent DCE-MRI using three-dimensional fast imaging with a steady-state precession sequence. Tumor cell proliferation and MVD of all surgical specimens were evaluated using immunohistochemical staining with CD34 and the antibody for proliferating cell nuclear antigen (PCNA). Regression analysis was used to statistically analyze the relationship between the PCNA labeling index or MVD and each of three DCE-MRI parameters: maximum CI (CI-max), maximum CI gain (CI-gain) and the CI-gain / CI-max ratio). The PCNA labeling index and MVD showed significant correlations with the CI-gain/CI-max ratio (P=0.0012, r=0.581 and P=0.00141, r=0.574, respectively). The assessment of DCE-MRI parameters may prove to be a valuable non-invasive method for assessing tumor cell proliferation and MVD of patients with oral cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027349     DOI: 10.1016/j.oraloncology.2008.09.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.

Authors:  Chengru Song; Peng Cheng; Jingliang Cheng; Yong Zhang; Mengtian Sun; Shanshan Xie; Xiaonan Zhang
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

2.  Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.

Authors:  Ravikumar Aalinkeel; Bindukumar Nair; Chih-Kuang Chen; Supriya D Mahajan; Jessica L Reynolds; Hanguang Zhang; Haotian Sun; Donald E Sykes; Kailash C Chadha; Steven G Turowski; Katelyn D Bothwell; Mukund Seshadri; Chong Cheng; Stanley A Schwartz
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

Review 3.  Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.

Authors:  S Gaddikeri; R S Gaddikeri; T Tailor; Y Anzai
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

4.  Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging.

Authors:  Mukund Seshadri; Nuno T Sacadura; Tonya Coulthard
Journal:  Angiogenesis       Date:  2011-09-07       Impact factor: 9.596

5.  Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.

Authors:  Antonello Vidiri; Emma Gangemi; Emanuela Ruberto; Rosella Pasqualoni; Rosa Sciuto; Giuseppe Sanguineti; Alessia Farneti; Maria Benevolo; Francesca Rollo; Francesca Sperati; Filomena Spasiano; Raul Pellini; Simona Marzi
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

6.  Relationship between histogram metrics of pharmacokinetic parameters of DCE-MRI and histological phenotype in breast cancer.

Authors:  Guocai Yang; Jing Yang; Hui Xu; Qingxin Zhang; Yonghong Qi; Aiju Zhang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.